EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A system for providing specialized medical care for comorbidities including gout and hyperuricemia during Covid-19

Nazgul Omurzakova, Idayat Tasheva, Aigerim Djakesheva, Samat Satybaldiev, Nadira Kushubakova, Aykerim Beksultan kyzy, Jaynagul Kerimbekova, Ryskul Kydyralieva, Akpay Sarybaev

Medical Research Archives · 30.06.2026 · 14 (6)

DOI: 10.18103/mra.2026.0338 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Research Archives, online erschienen am 30.06.2026. Verfasst von Nazgul Omurzakova und 8 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The purpose of the study was to examine the features of organising specialised care for patients with coronavirus infection and chronic diseases, followed by an assessment of its effectiveness and possibilities for improvement. The study had a theoretical-analytical character and included a comparison of six clusters: Kyrgyzstan as an example of a country with limited resources, the USA, European states (France, Germany, Italy, Spain, Poland), Asian countries (Thailand, Singapore, Indonesia, South Korea, India, Malaysia), as well as China and Japan with the centralised organisational models. The analysis was based on publications, statistics and clinical guidelines from 2020-2025; cross-country comparison was applied with a conditional points-based assessment of severity in comorbid patients and the development of recommendations for improving care. The analysis showed that in multimorbidity the severity score reached 16 points, and in cardiovascular, respiratory diseases and immunodeficiencies - 15. Two or more chronic pathologies increased the risk of severe course and death by 2-3 times. In China and Japan, in-hospital mortality was 5.5-6%, with severe renal failure in Japan - up to 28%. In the USA the mortality among patients with several chronic diseases exceeded 12% with an overall rate of 2.5%, the load on emergency departments reached 25-30%. In Europe the increase in mortality in peak periods was about 20%, with resource deficits - up to 50-60%, among oncology patients in Italy and Spain - more than 25%. In Kyrgyzstan with multidrug-resistant tuberculosis, the indicator reached 34-36%. The obtained data confirm the dependence of outcomes on the severity of comorbidities and health-care resources, which requires risk stratification, adaptation of protocols and strengthening of staffing and infrastructure potential. The results can be used by health authorities and medical institutions to optimise care for patients with coronavirus infection and chronic diseases.

Zitieren

APA

Omurzakova, N., Tasheva, I., Djakesheva, A., Satybaldiev, S., Kushubakova, N., kyzy, A. B., Kerimbekova, J., Kydyralieva, R., & Sarybaev, A. (2026). A system for providing specialized medical care for comorbidities including gout and hyperuricemia during Covid-19. Medical Research Archives, 14(6). https://doi.org/10.18103/mra.2026.0338

Vancouver

Omurzakova N, Tasheva I, Djakesheva A, Satybaldiev S, Kushubakova N, kyzy AB, et al. A system for providing specialized medical care for comorbidities including gout and hyperuricemia during Covid-19. Medical Research Archives. 2026;14(6). doi:10.18103/mra.2026.0338

BibTeX
@article{Omurzakova2026,
  author = {Omurzakova, Nazgul and Tasheva, Idayat and Djakesheva, Aigerim and Satybaldiev, Samat and Kushubakova, Nadira and kyzy, Aykerim Beksultan and Kerimbekova, Jaynagul and Kydyralieva, Ryskul and Sarybaev, Akpay},
  title = {A system for providing specialized medical care for comorbidities including gout and hyperuricemia during Covid-19},
  journal = {Medical Research Archives},
  year = {2026},
  volume = {14},
  number = {6},
  doi = {10.18103/mra.2026.0338}
}
Kostenlos starten →